维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Bendtzen"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management显示文摘	Signe Larsen Klaus Bendtzen Ole Haagen Nielsen	2010	Annals of Medicine2010，，2：	2
2	Clinical implications of variations in anti‐infliximab antibody levels in patients with inflammatory bowel disease显示文摘	Casper Steenholdt Magid Al‐khalaf J?rn Brynskov Klaus Bendtzen Ole ?. Thomsen Mark A. Ainsworth	2012	Inflamm Bowel Dis2012，，12：	1
3	Prognostic laboratory markers of joint damage in rheumatoid arthritis 显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，：	1
4	Prognostic laboratorymarkers of joint damage in rheumatoid arthritis显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，：	1
5	Sp ironolactone inhibits Production of p roinflammatory cytokines by human mononuelear cells显示文摘	Hansen PR Rieneck K Bendtzen K	2004	Immunol Lett2004，91，1：	1
6	Polymor- phisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with ag- gressive periodontitis, juvenile idiopathic arthritis,and rheumatoid arthritis 显示文摘	Havemose-Poulsen A Sorensen LK Bendtzen K	2007	J Periodontol2007，78，：	1
7	Prognostic laboratory markers of joint damage in rheumatoid arthritis 显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，2：	1
8	Interleukin26 effects on insulin secretion and glucose of rat pancreatic islets in Vitro显示文摘	Sandler S Bendtzen K Eizirik DL	1990	En-docrinology1990，126，5：	1
9	Prognostic laboratory markers of joint damage in rheumatoid arthritis显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，：	1
10	Inhibition of human T lymphocyteproliferation and cytokine production by 1,25-dihydroxyvitamin D3 Differential effects on CD45RA+andCD45R0+cells显示文摘	Muller K Bendtzen K	1992	Autoimmunity1992，14，：	1
11	Effects of 1, 25 - dihydroxyvita- min D3 and the analogues MC903 and KH1060 on interleukin - 1 beta - induced inhibition of rat pancreatic islet beta - cell function in vitro 显示文摘	Sandler S Buschard K Bendtzen K	1994	Immunol Lett1994，41，1：	1
12	Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model 显示文摘	ALAMILI M BENDTZEN K LYKKESFELDT J	2014	J Crit Care2014，29，1：	1
13	Immunoregulation by naturally occurringand disease-associated autoantibodies : binding to cytokines and theirrole in regulation of T-cell responses显示文摘	Nielsen CH Bendtzen K	2012	Adv Exp Med Biol2012，750，：	1
14	Prognostic laboratory markers of joint damage in rheu- matoid arthritis显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，：	1
15	Prognostic laboratory markers of joint damage in rheumatoid arthritis显示文摘	Lindqvist E Eberhardt K Bendtzen K	2005	Ann Rheum Dis2005，64，：	1
16	Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro显示文摘	Sandler S Bendtzen K Eizirik DL	1990	Endocrinology1990，126，2：	1
17	Differential release of inte rleukin-6 from human gestational tissues in association with labor and in vitr o endotoxin treatment显示文摘	Laham N Brennecke SP Bendtzen K	1996	J Endocrine1996，149，：	1
18	Spironolactone inhibits production of proinflammatory cytokines, including turnout necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis 显示文摘	Bendtzen K Hansen PR Rieneck K	2003	Clin Exp Immunol2003，134，4：	1
19	Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells显示文摘	A. Roeske-Nielsen P. Fredman J.E. Mansson K. Bendtzen K. Buschard	2004	Immunology Letters2004，，2：	1
20	Clini- cal implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease: post hoe analysis of a randomized controlled trial 显示文摘	STEENHOLDT C BENDTZEN K BRYNSKOV J	2014	Am J Gastroenterol2014，109，7：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示